Adverse Event Reporting News - Ziagen, Videx under safety review by FDA and EMEA
April 8, 2008 -- Both FDA and the European Medicines Agency (EMEA) are looking closely at the potential risks of GlaxoSmithKline's Ziagen (abacavir) and Bristol...
Chain Drug Review - FDA probes Ziagen mislabeling
June 10, 2002 -- The FDA is trying to determine how several sealed bottles of Ziagen were mislabeled and then sold to patients who assumed they were receiving a...
Chemistry and Industry - Ziagen can kill
September 4, 2000 -- Glaxo Welicome's potent anti-AIDS drug, ziagen, is back in the news following the re-issue of recommendations for stringent monitoring against fatal...
Medical Marketing and Media - Glaxo toughens warning on Ziagen
September 1, 2000 -- For the second time this year, Glaxo Wellcome has strengthened the black box label warning about severe or fatal hypersensitivity reactions to its...
Chain Drug Review - Genetic test urged before giving drug
August 18, 2008 -- The Food and Drug Administration is urging physicians to use a genetic test to screen patients before prescribing abacavir (Ziagen), a drug used to...
AFP - Common AIDS drug linked to risk of heart attack: Lancet study
April 2, 2008 -- PARIS (AFP) — Ziagen, one of the most widely-used AIDS drugs, may boost the risk of a heart attack, a long-term study published online on...
Independent, The (London) - GSK Aids drug faces FDA safety review
March 28, 2008 -- Business News IN BRIEF *The US drug regulator is reviewing the safety of an Aids drug sold by GlaxoSmithKline after a study showed a higher...
Chain Drug Review - Panel backs Glaxo Wellcome's Ziagen
December 7, 1998 -- An FDA advisory panel has recommended agency clearance of Ziagen, an investigational HIV drug by Glaxo Wellcome Inc. An accelerated approval process...
HealthDay - Test Detects Sensitivity to HIV Drug
February 6, 2008 -- New research suggests that an expensive blood test could help a small minority of HIV patients discover whether they should avoid a common AIDS drug...
Adverse Event Reporting News - GSK says tampering caused mislabeling of HIV medications
April 23, 2007 -- GlaxoSmithKline and FDA informed healthcare professionals of an apparent third-party tampering that resulted in the misbranding of Ziagen as Combivir...
